209 related articles for article (PubMed ID: 34343339)
1. Cost-effectiveness of secondary fracture prevention intervention for Medicare beneficiaries.
Nayak S; Singer A; Greenspan SL
J Am Geriatr Soc; 2021 Dec; 69(12):3435-3444. PubMed ID: 34343339
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
Moriwaki K; Noto S
Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.
Yong JH; Masucci L; Hoch JS; Sujic R; Beaton D
Osteoporos Int; 2016 Jan; 27(1):231-40. PubMed ID: 26275439
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of a multifaceted intervention to improve quality of osteoporosis care after wrist fracture.
Majumdar SR; Lier DA; Rowe BH; Russell AS; McAlister FA; Maksymowych WP; Hanley DA; Morrish DW; Johnson JA
Osteoporos Int; 2011 Jun; 22(6):1799-808. PubMed ID: 20878389
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study.
Cooper MS; Palmer AJ; Seibel MJ
Osteoporos Int; 2012 Jan; 23(1):97-107. PubMed ID: 21953475
[TBL] [Abstract][Full Text] [Related]
7. Cost-Utility Analysis of the Ontario Fracture Screening and Prevention Program.
Saunders H; Sujic R; Bogoch ER; Jain R; Jinah A; Elliot-Gibson V; Mendlowitz AB; Linton D; Inrig T; Isaranuwatchai W; Sale JEM
J Bone Joint Surg Am; 2021 Jul; 103(13):1175-1183. PubMed ID: 33764937
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Osteoporosis Interventions to Improve Quality of Care After Upper Extremity Fracture: Results From a Randomized Trial (C-STOP Trial).
Majumdar SR; Lier DA; McAlister FA; Johnson JA; Rowe BH; Beaupre LA
J Bone Miner Res; 2019 Jul; 34(7):1220-1228. PubMed ID: 30779861
[TBL] [Abstract][Full Text] [Related]
9. A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical program.
Beaupre LA; Lier D; Smith C; Evens L; Hanson HM; Juby AG; Kivi P; Majumdar SR;
Arch Osteoporos; 2020 Jul; 15(1):113. PubMed ID: 32699946
[TBL] [Abstract][Full Text] [Related]
10. Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature.
Wu CH; Kao IJ; Hung WC; Lin SC; Liu HC; Hsieh MH; Bagga S; Achra M; Cheng TT; Yang RS
Osteoporos Int; 2018 Jun; 29(6):1227-1242. PubMed ID: 29460102
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial.
Majumdar SR; Lier DA; Leslie WD
J Clin Endocrinol Metab; 2013 May; 98(5):1991-2000. PubMed ID: 23596140
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.
Moriwaki K; Fukuda H
Osteoporos Int; 2019 Feb; 30(2):299-310. PubMed ID: 30610244
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures.
Nelson SD; Nelson RE; Cannon GW; Lawrence P; Battistone MJ; Grotzke M; Rosenblum Y; LaFleur J
Osteoporos Int; 2014 Dec; 25(12):2701-7. PubMed ID: 25037601
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom.
Svedbom A; Hadji P; Hernlund E; Thoren R; McCloskey E; Stad R; Stollenwerk B
Osteoporos Int; 2019 Sep; 30(9):1745-1754. PubMed ID: 31270592
[TBL] [Abstract][Full Text] [Related]
15. Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted?
Gajic-Veljanoski O; Bayoumi AM; Tomlinson G; Khan K; Cheung AM
Osteoporos Int; 2012 Nov; 23(11):2681-92. PubMed ID: 22398856
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
Mori T; Crandall CJ; Ganz DA
Osteoporos Int; 2017 Feb; 28(2):585-595. PubMed ID: 27726000
[TBL] [Abstract][Full Text] [Related]
17. Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision.
McLellan AR; Wolowacz SE; Zimovetz EA; Beard SM; Lock S; McCrink L; Adekunle F; Roberts D
Osteoporos Int; 2011 Jul; 22(7):2083-98. PubMed ID: 21607809
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Screening for Osteoporosis in Older Men With a History of Falls.
Ito K
JAMA Netw Open; 2020 Dec; 3(12):e2027584. PubMed ID: 33258906
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
Mori T; Crandall CJ; Ganz DA
Osteoporos Int; 2017 May; 28(5):1733-1744. PubMed ID: 28210776
[TBL] [Abstract][Full Text] [Related]
20. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment.
King AB; Saag KG; Burge RT; Pisu M; Goel N
Osteoporos Int; 2005 Dec; 16(12):1545-57. PubMed ID: 15942702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
